WILLIAMS AND JENSEN, PLLC for GENENTECH INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
R&D Tax Credit Extension; TARP; H.R. 1429.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID E FRANASIAK | — |
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
Budget/Appropriations BUD
H.R. 2638 (Consoldidated Security, Disaster Assistance and Continuing Appropriations Act); Comparative Effectiveness legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Copyright/Patent/Trademark CPT
Intellectual property issues; H.R. 5629 (Pathways to Biosimilars Act).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Health Issues HCR
H.R. 6331/ S. 3101 (Medicare Improvements for Patients and Providers Act); H.R. 5629 (Pathway for Biosimilars Act); FDA Reform; Medicare Drug Benefit
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Medicare/Medicaid MMM
H.R. 1424 (Emergency Economic Stabilization Act); S. 2029 (Physician Payments Sunshine Act); H.R. 6331/S. 3101 (Medicare Improvenents for Patients and Providers Act); Comparative Effectiveness Legislation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| CHRISTOPHER W HATCHER | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Pharmacy PHA
H.R. 1038/S.623 (Access to Life-Saving Medicine Act, follow-on biologics); H.R. 1956 (Patient Protection and Innovative Biologic Medicines Act, follow-on biologics); H.R. 5629 (Pathway for Biosimilars Act); H.R. 5839 (Safeguarding America's Pharmaceuticals Act); S.1505 (Affordable Biologics for Consumers Act, follow-on biologics); S. 1695 (Biologics Price Competition and Innovation Act-follow-on biologics); S.2029 (Physician Payments Sunshine Act); S.596 (Safe Internet Pharmacy Act, clinical trials/drug safety)
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| KARINA LYNCH | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.